Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$5.9 - $6.95 $113,226 - $133,377
-19,191 Reduced 26.86%
52,256 $344,000
Q1 2023

Apr 13, 2023

BUY
$6.18 - $7.99 $14,776 - $19,104
2,391 Added 3.46%
71,447 $485,000
Q4 2022

Jan 18, 2023

BUY
$6.87 - $10.96 $7,240 - $11,551
1,054 Added 1.55%
69,056 $0
Q3 2022

Oct 20, 2022

BUY
$9.44 - $11.76 $641,938 - $799,703
68,002 New
68,002 $672,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $247M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Summer Haven Investment Management, LLC Portfolio

Follow Summer Haven Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summer Haven Investment Management, LLC with notifications on news.